Japan, Jan. 16 -- SHANGHAI NOVAMAB BIOPHARMACEUTICALS CO LTD has got intellectual property rights for 'ANTI-TSLP NANOBODY AND APPLICATIONS THEREFOR.' Other related details are as follows:
Application Number: JP,2024-146304
Category (FI): A61K39/395@L,A61K39/395@N,A61K47/68,A61K51/10,200,A61P11/00,A61P11/06,A61P37/08,C07K16/00,C07K16/24,C07K16/46,C07K19/00,C12N1/15,C12N1/19,C12N1/21,C12N15/13,C12N15/62@Z,C12N15/63@Z,C12N5/10,C12P21/00@C,C12P21/08
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Aug. 28, 2024
Publication Date: Dec. 3, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.